Mapping Array Library Sample Clauses
The Mapping Array Library clause defines the terms and conditions governing the use, distribution, or integration of a software library designed for mapping arrays. Typically, this clause outlines the permitted uses of the library, any licensing requirements, and restrictions on modification or redistribution. For example, it may specify whether the library can be incorporated into commercial products or if attribution is required. The core function of this clause is to ensure that both the provider and users of the mapping array library understand their rights and obligations, thereby reducing legal ambiguity and managing intellectual property risks.
Mapping Array Library. After SB screens the Compass Array Library and thereafter at any point during additional screening activities (as described below) on Available Compounds from the Compass Array Library, and as determined by SB in consultation with the JSC, SB may screen one or more Mapping Array Libraries corresponding to any Active Compound(s) identified from the Compass Array Library to obtain initial structure-activity relationship ("SAR") data with respect to those Active Compounds and to
Mapping Array Library. During the period from the Effective Date through March 31, 2003 upon the written request of Sankyo, ArQule will promptly deliver to Sankyo any Mapping Array Libraries selected by Sankyo. Promptly upon its receipt of any such Mapping Array Libraries, Sankyo shall test such Mapping Array Libraries for activity against the relevant Targets. In addition, Sankyo may continue to screen all Mapping Array Libraries received prior to the Effective Date against any Targets. Initially, ArQule will identify the Chemical Themes of each Mapping Array Library in Markush format but not the structures of the individual ArQule Compounds in the Mapping Array Library, and Sankyo will not disclose the Targets screened. If Sankyo detects Active Compounds, Sankyo shall promptly provide ArQule with notice by telefax communication of the spatial location of Active Compounds in the Mapping Array Libraries, which telefax shall be followed by a confirmatory letter.
Mapping Array Library. Upon receipt of each Mapping Array Library, or upon receipt of the relevant information as described in Section 3.3. in the case of Mapping Array Libraries already in the possession of Solvay, Solvay shall diligently screen such Mapping Array Library for activity against the relevant Target(s). ArQule will maintain the reserved status of the Available Compound(s) identified in the Compass Array Library for a period of four (4) months after Solvay receives the relevant Mapping Array Library and accompanying information or, in the case of Mapping Array Libraries already in the possession of Solvay, for a period of four (4) months after Solvay receives the relevant information as described in Section 3.3. In addition, Solvay shall have the right to screen all Mapping Array Libraries in its possession irrespective of the Compass Array Library. If Solvay detects and confirms Active Compounds, Solvay shall inform ArQule through the Research Committee in writing (including by electronic mail) of the spatial location of Active Compounds in the Mapping Array Libraries. ArQule will promptly determine whether the Active Compounds identified by Solvay in the Mapping Array Libraries are Available Compounds, and then notify Solvay of such determination. If any Active Compound is not an Available Compound, ArQule shall not disclose the structure and Solvay shall have no rights under this Agreement with respect to that Active Compound. If an Active Compound is an Available Compound, ArQule shall reserve such Active Compound as an Available Compound to Solvay under this Agreement. ArQule then shall disclose to Solvay the structure of such Available Compound correlated to its well location, and Solvay shall disclose to ArQule the class of the Target involved. All such disclosed structures and the target class shall be treated as Confidential Information. ArQule shall maintain the reserved status of every Active Compound that is an Available Compound from the same Mapping Array Library for a period of up to four (4) weeks after the date upon which the last structure of these Available Compounds is disclosed to Solvay. If Solvay requests resynthesis of one or more Available Compounds from the same Mapping Array Library during the four-week reservation period, the Research Committee will determine which of these Available Compounds if not all would become a Licensed Compound Set if the resynthesized compounds are confirmed to be Active Compounds, and ArQule will continue to re...
Mapping Array Library. Upon receipt of each Mapping Array Library, or upon receipt of the relevant information as described in Section 3.3. in the case of Mapping Array Libraries already in the possession of Solvay, Solvay shall diligently screen such Mapping Array Library for activity against the relevant Target(s). ArQule will maintain the reserved status of the Available Compound(s) identified in the Compass Array Library for a period of
Mapping Array Library. During the period from the [*****] upon the written request of Sankyo, ArQule will promptly deliver to Sankyo any Mapping Array Libraries selected by Sankyo. Promptly upon its receipt of any such Mapping Array Libraries, Sankyo shall test such Mapping Array Libraries for activity against the relevant Targets. In addition, Sankyo may continue to screen all Mapping Array Libraries received prior to the Effective Date against any Targets. Initially, ArQule will identify the Chemical Themes of each Mapping Array Library in [*****] but not the structures of the individual ArQule Compounds in the Mapping Array Library, and Sankyo will not disclose the Targets screened. If Sankyo detects Active Compounds, Sankyo shall promptly provide ArQule with notice by telefax communication of the spatial location of Active Compounds in the Mapping Array Libraries, which telefax shall be followed by a confirmatory letter.